ROCKWELL MEDICAL, INC. Available-for-sale Securities, Gross Realized Gains
ROCKWELL MEDICAL, INC. (RMTI) reported Available-for-sale Securities, Gross Realized Gains of $2.41 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGains · last filed 2018-11-09
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized gains for the quarter ending 2018-09-30 was $2.41K, a 4129.82% increase year-over-year.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized gains for the quarter ending 2018-06-30 was $2.21K.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized gains for the quarter ending 2018-03-31 was $1.43K.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized gains for the quarter ending 2017-12-31 was $12.87K.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized gains for fiscal 2017 was $12.93K, a 91.74% decline from fiscal 2016.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized gains for fiscal 2016 was $156.46K.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized gains for fiscal 2014 was $28.43K.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized gains for fiscal 2012 was $10.44K.
| Period end | Available-for-sale Securities, Gross Realized Gains 3 month | Available-for-sale Securities, Gross Realized Gains 6 month | Available-for-sale Securities, Gross Realized Gains 9 month | Available-for-sale Securities, Gross Realized Gains 12 month |
|---|---|---|---|---|
| 2018-09-30 | $2.41K 10-Q · filed 2018-11-09 | $4.62K derived: sum of 2 quarters · filed 2018-11-09 | $6.05K 10-Q · filed 2018-11-09 | $18.92K derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | $2.21K 10-Q · filed 2018-08-14 | $128.63K 10-Q · filed 2018-08-14 | $16.51K derived: sum of 3 quarters · filed 2018-08-14 | $16.57K derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-03-31 | $1.43K 10-Q/A · filed 2018-08-14 | $14.29K derived: sum of 2 quarters · filed 2018-08-14 | $14.35K derived: sum of 3 quarters · filed 2018-11-09 | |
| 2017-12-31 | $12.87K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $12.93K derived: sum of 2 quarters · filed 2018-11-09 | $12.93K 10-K · filed 2018-03-15 | |
| 2017-09-30 | $57.00 10-Q · filed 2018-11-09 | $57.00 10-Q · filed 2018-11-09 | ||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | $156.46K 10-K · filed 2018-03-15 | |||
| 2016-09-30 | $156.46K 10-Q · filed 2016-11-07 | $263.34K derived: sum of 2 quarters · filed 2016-11-07 | ||
| 2016-06-30 | $106.88K 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $28.43K 10-K · filed 2016-02-29 | |||
| 2012-12-31 | $10.44K 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |